Literature DB >> 26480975

Recognition and Management of Hypertension in Older Persons: Focus on African Americans.

Carolyn H Still1,2, Keith C Ferdinand3, Gbenga Ogedegbe4, Jackson T Wright2,5.   

Abstract

UNLABELLED: Hypertension is the most commonly diagnosed condition in persons aged 60 and older and is the single most important risk factor for cardiovascular disease (ischemic heart disease, heart failure, and stroke), kidney disease, and dementia. More than half of individuals with hypertension in the United States are aged 60 and older. Hypertension disproportionately affects African Americans, with all age groups, including elderly adults, having a higher burden of hypertension-related complications than other U.S. POPULATIONS: Multiple clinical trials have demonstrated the beneficial effects of blood pressure (BP) reduction on cardiovascular morbidity and mortality, with most of the evidence in individuals aged 60 and older. Several guidelines have recently been published on the specific management of hypertension in individuals aged 60 and older, including in high-risk groups such as African Americans. Most recommend careful evaluation, thiazide diuretics and calcium-channel blockers for initial drug therapy in most African Americans, and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in those with chronic kidney disease or heart failure. Among the areas of controversy is the recommended target BP in African Americans aged 60 and older. A recent U.S. guideline recommended raising the systolic BP target from less than 140 mmHg to less than 150 mmHg in this population. This article will review the evidence and current guideline recommendations for hypertension treatment in older African Americans, including the rationale for continuing to recommend a SBP target of less than 140 mmHg in this population.
© 2015, Copyright the Authors Journal compilation © 2015, The American Geriatrics Society.

Entities:  

Keywords:  African Americans; clinical trials; hypertension; management of hypertension

Mesh:

Substances:

Year:  2015        PMID: 26480975      PMCID: PMC6310911          DOI: 10.1111/jgs.13672

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  59 in total

1.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Authors:  William C Cushman; Charles E Ford; Jeffrey A Cutler; Karen L Margolis; Barry R Davis; Richard H Grimm; Henry R Black; Bruce P Hamilton; Joanne Holland; Chuke Nwachuku; Vasilios Papademetriou; Jeffery Probstfield; Jackson T Wright; Michael H Alderman; Robert J Weiss; Linda Piller; Judy Bettencourt; Sandra M Walsh
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

Review 2.  Clinical practice. Isolated systolic hypertension in the elderly.

Authors:  Aram V Chobanian
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245

3.  Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients--evidence from the Systolic Hypertension in Europe Trial.

Authors:  J A Staessen; L Thijs; H Celis; J Gasowski; J G Wang; R H Fagard
Journal:  S Afr Med J       Date:  2001-12

4.  Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.

Authors:  Alberto Zanchetti; Stevo Julius; Sverre Kjeldsen; Gordon T McInnes; Tsushung Hua; Michael Weber; John H Laragh; Francis Plat; Edouard Battegay; Cesar Calvo-Vargas; Andrzej Cieśliński; Jean Paul Degaute; Nicolaas J Holwerda; Janna Kobalava; Ole Lederballe Pedersen; Faustinus P Rudyatmoko; Kostas C Siamopoulos; Oyvind Störset
Journal:  J Hypertens       Date:  2006-11       Impact factor: 4.844

5.  Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial.

Authors:  Lawrence J Appel; Frank M Sacks; Vincent J Carey; Eva Obarzanek; Janis F Swain; Edgar R Miller; Paul R Conlin; Thomas P Erlinger; Bernard A Rosner; Nancy M Laranjo; Jeanne Charleston; Phyllis McCarron; Louise M Bishop
Journal:  JAMA       Date:  2005-11-16       Impact factor: 56.272

6.  The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.

Authors:  Lisheng Liu; Yuqing Zhang; Guozhang Liu; Wei Li; Xuezhong Zhang; Alberto Zanchetti
Journal:  J Hypertens       Date:  2005-12       Impact factor: 4.844

7.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

8.  Treatment of hypertension in patients 80 years of age or older.

Authors:  Nigel S Beckett; Ruth Peters; Astrid E Fletcher; Jan A Staessen; Lisheng Liu; Dan Dumitrascu; Vassil Stoyanovsky; Riitta L Antikainen; Yuri Nikitin; Craig Anderson; Alli Belhani; Françoise Forette; Chakravarthi Rajkumar; Lutgarde Thijs; Winston Banya; Christopher J Bulpitt
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

9.  Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study.

Authors:  Stevo Julius; Michael H Alderman; Gareth Beevers; Björn Dahlöf; Richard B Devereux; Janice G Douglas; Jonathan M Edelman; Katherine E Harris; Sverre E Kjeldsen; Shawna Nesbitt; Otelio S Randall; Jackson T Wright
Journal:  J Am Coll Cardiol       Date:  2004-03-17       Impact factor: 24.094

Review 10.  Vascular risk factors, cognitive decline, and dementia.

Authors:  E Duron; Olivier Hanon
Journal:  Vasc Health Risk Manag       Date:  2008
View more
  8 in total

1.  The Reproducibility of Racial Differences in Ambulatory Blood Pressure Phenotypes and Measurements.

Authors:  Aamir Husain; Feng-Chang Lin; Laura A Tuttle; Emily Olsson; Anthony J Viera
Journal:  Am J Hypertens       Date:  2017-10-01       Impact factor: 2.689

2.  Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults.

Authors:  Shanna L Burke; Tamara Cadet; Marlaina Maddux
Journal:  J Natl Med Assoc       Date:  2017-07-18       Impact factor: 1.798

Review 3.  Medication adherence in the older adults with chronic multimorbidity: a systematic review of qualitative studies on patient's experience.

Authors:  M Maffoni; S Traversoni; E Costa; L Midão; P Kardas; M Kurczewska-Michalak; A Giardini
Journal:  Eur Geriatr Med       Date:  2020-03-30       Impact factor: 1.710

4.  Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial.

Authors:  Carolyn H Still; Timothy E Craven; Barry I Freedman; Peter N Van Buren; Kaycee M Sink; Anthony A Killeen; Jeffrey T Bates; Alberta Bee; Gabriel Contreras; Suzanne Oparil; Carolyn M Pedley; Barry M Wall; Suzanne White; Delia M Woods; Carlos J Rodriguez; Jackson T Wright
Journal:  J Am Soc Hypertens       Date:  2015-08-07

5.  Changes in Cardiovascular Health Status and the Risk of New-Onset Hypertension in Kailuan Cohort Study.

Authors:  Fei Gao; Xiaoxue Liu; Xizhu Wang; Shouhua Chen; Jihong Shi; Ying Zhang; Shouling Wu; Jun Cai
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

6.  Racial disparities in renal cell carcinoma: a single-payer healthcare experience.

Authors:  Abiodun Mafolasire; Xiaopan Yao; Cayce Nawaf; Alfredo Suarez-Sarmiento; Wong-Ho Chow; Wei Zhao; Douglas Corley; Jonathan N Hofmann; Mark Purdue; Adebowale J Adeniran; Brian Shuch
Journal:  Cancer Med       Date:  2016-05-26       Impact factor: 4.452

7.  Antihypertensive Medication and Dementia Risk in Older Adult African Americans with Hypertension: A Prospective Cohort Study.

Authors:  Michael D Murray; Hugh C Hendrie; Kathleen A Lane; Mengjie Zheng; Roberta Ambuehl; Shanshan Li; Frederick W Unverzagt; Christopher M Callahan; Sujuan Gao
Journal:  J Gen Intern Med       Date:  2018-01-12       Impact factor: 5.128

8.  Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial.

Authors:  Carolyn H Still; Carlos J Rodriguez; Jackson T Wright; Timothy E Craven; Adam P Bress; Glenn M Chertow; Paul K Whelton; Jeffrey C Whittle; Barry I Freedman; Karen C Johnson; Capri G Foy; Jiang He; John B Kostis; James P Lash; Carolyn F Pedley; Roberto Pisoni; James R Powell; Barry M Wall
Journal:  Am J Hypertens       Date:  2017-12-08       Impact factor: 2.689

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.